|
|
Suppliers for
Fruquintinib
|
Properties | CAS |
1194506-26-7 |
|
3 Registered suppliers
Description : Fruquintinib, also known as HMPL-013, is an orally available, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), with potential anti-angiogenic and antineoplastic activities. - Molecular Weight :393.39
- Purity :98%
Molecular Formula : C21H19N3O5 Canonical SMILES : O=C(C1=C(C)OC2=CC(OC3=C4C=C(OC)C(OC)=CC4=NC=N3)=CC=C12)NC Solubility : Soluble in DMSO, not in water Appearance : Solid powder Storage : Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). Synonyms : Fruquintinib; HMPL013; HMPL 013; HMPL-013.
More details are to be found here
Description : Fruquintinib, also known as HMPL-013, is an orally available, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), with potential anti-angiogenic and antineoplastic activities. - Molecular Weight :393.39
- Purity :98%
Molecular Formula : C21H19N3O5 Canonical SMILES : O=C(C1=C(C)OC2=CC(OC3=C4C=C(OC)C(OC)=CC4=NC=N3)=CC=C12)NC Solubility : Soluble in DMSO, not in water Appearance : Solid powder Storage : Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). Synonyms : Fruquintinib; HMPL013; HMPL 013; HMPL-013.
More details are to be found here
|
Properties:
... more properties and specification on Fruquintinib
|
|
Privileged suppliers
Last update 2024-06-18
|